Form 6K Immuron Ltd ADR For: 16 December
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immuron Ltd ADR (IMRN)
Assess today's live Immuron Ltd ADR (IMRN) share price, performance and insights using our live NASDAQ: IMRN stock exchange data.
Analyse the historical data and Immuron Ltd ADR share price performance charts on this page. Our technical summary section provides analysis on Immuron share price buy/sell indicators using real-time data (or discuss the Immuron (IMRN) stock price today with other investors in the Immuron NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IMRN share price (ISIN: US45254U1016) to enhance your trading decisions with our free investment tools and resources.
What Is the Immuron Ltd ADR Share Price Today?
The Immuron share price today is 0.913.
What Is the Stock Symbol for Immuron Ltd ADR
The stock symbol (or 'ticker') for Immuron Ltd ADR is "IMRN."
What Stock Exchange Does Immuron Ltd ADR Trade On?
Immuron Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Immuron Ltd ADR a Good Stock to Buy?
Determining whether Immuron Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Immuron Ltd ADR share price performance charts on this page. Our technical summary section provides analysis on Immuron share price buy/sell indicators using real-time data (or discuss the Immuron (IMRN) stock price today with other investors in the Immuron NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IMRN share price (ISIN: US45254U1016) to enhance your trading decisions with our free investment tools and resources.
What Is the Immuron Ltd ADR Share Price Today?
The Immuron share price today is 0.913.
What Is the Stock Symbol for Immuron Ltd ADR
The stock symbol (or 'ticker') for Immuron Ltd ADR is "IMRN."
What Stock Exchange Does Immuron Ltd ADR Trade On?
Immuron Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Immuron Ltd ADR a Good Stock to Buy?
Determining whether Immuron Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.909
0.940
52 wk Range
0.909
2.483
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9090.940
52 wk Range
0.9092.483
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMRN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 6K Immuron Ltd ADR For: 4 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 15 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 3 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 12 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 16 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 15 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 12 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 5 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Immuron Company Profile
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers’ diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.
Compare IMRN to Peers and Sector
Metrics to compare | IMRN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMRNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | −7.5x | −0.6x | |
PEG Ratio | −0.09 | −0.14 | 0.00 | |
Price/Book | 1.5x | 6.6x | 2.6x | |
Price / LTM Sales | 1.7x | 20.0x | 3.2x | |
Upside (Analyst Target) | 336.6% | 143.8% | 41.8% | |
Fair Value Upside | Unlock | −9.5% | 5.1% | Unlock |
Earnings
Latest Release
Dec 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Immuron (IMRN) Share Price Today?
The live Immuron share price today is 0.913
What Stock Exchange Does Immuron (IMRN) Trade On?
Immuron is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Immuron?
The stock symbol (also called a 'ticker') for Immuron is "IMRN."
What Is the Current Immuron Market Cap?
As of today, Immuron market capitalisation is 8.30M.
What Is Immuron's (IMRN) Earnings Per Share (TTM)?
The Immuron EPS is currently -0.02 (Trailing Twelve Months).
When Is the Next Immuron Earnings Date?
Immuron's next earnings report will be released on 04 Mar 2026.
Is IMRN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Immuron moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Immuron Stock Split?
Immuron has split 0 times. (See the IMRN stock split history page for full effective split date and price information.)
How Many Employees Does Immuron Have?
Immuron has 7 employees.
What is the current trading status of Immuron (IMRN)?
As of 24 Dec 2025, Immuron (IMRN) is trading at a price of 0.913, with a previous close of 0.943. The stock has fluctuated within a day range of 0.909 to 0.940, while its 52-week range spans from 0.909 to 2.483.
What Is Immuron (IMRN) Price Target According to Analysts?
The average 12-month price target for Immuron is USD4.11788238, with a high estimate of USD4.11788238 and a low estimate of USD4.11788238. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +351.03% Upside potential.
What Is the IMRN After Hours Price?
IMRN's last after hours stock price is 0.910, the stock has decreased by -0.003, or -0.330%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.